Overview
Michael Keller, MD, is a pediatric immunologist, the director of the Translational Research Laboratory in the Cellular Therapy Program and associate professor of Pediatrics at Children’s National Hospital and George Washington University. He specializes in the diagnosis and treatment of primary and secondary immunodeficiency disorders. Dr. Keller’s research interests are in the application of cellular therapies to treat and prevent viral illnesses in immunocompromised patients, including children with inborn errors of immunity and patients undergoing bone marrow transplantation. He has led 10 investigator-initiated trials of virus-specific T cell therapy on which over 180 patients have been treated over the past decade, including national consortium studies. He is also co-lead of the joint NIAID-Children’s National clinical immunology research program (with Dr. Luigi Notarangelo) and has contributed to the descriptions of many new inborn errors of immunity. Dr. Keller has served on multiple national committees, including as chair of the Primary Immunodeficiency Committee for the American Academy of Asthma, Allergy and Immunology (2018-2022) and vice-chair of the Cellular Therapy Committee for the Pediatric Transplantation and Cellular Therapy Consortium (2022-present). He also serves as an author and section editor for multiple topics on inborn errors of immunity on uptodate.com. Dr. Keller lives in Maryland with his wife and two sons, and enjoys travel, hiking and martial arts. Publications ORCiD.
His clinical expertise encompasses Primary Ciliary Dyskinesia (PCD).
Dr. Keller is board certified in Allergy And Immunology: American Board Of Allergy And Immunology, 2012 and Pediatrics: American Board Of Pediatrics, 2010.
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
9850 Key West Avenue, Rockville, MD 20850
Ozlem Goker-Alpan MD LLC
Ozlem Goker-Alpan is a Pediatrics provider practicing medicine in Fairfax, Virginia. Dr. Goker-Alpan is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Gaucher Disease, Fabry Disease, Gaucher Disease Type 1, and Gaucher Disease Type 3. Dr. Goker-Alpan is currently accepting new patients.
William Gahl is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Bethesda, Maryland. Dr. Gahl is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Oculocutaneous Albinism Type 2, Hermansky-Pudlak Syndrome, Oculocutaneous Albinism Type 1, Oculocutaneous Albinism, and Deep Brain Stimulation.
Montgomery County
Michael Hsieh, MD, PhD, is a urologist at Children's National Hospital. Dr. Hsieh has experience in laparoscopic and robotic surgery for urologic conditions and specializes in bladder diseases affecting children and young adults. He is board-certified in urology and holds the certificate of added qualification in pediatric urology. Dr. Hsieh was recruited to Children’s National and the George Washington University to serve as Director of Transitional Urology. This joint venture is the East Coast's first clinical program dedicated to the care of adolescents and young adults with congenital urologic disorders. Many of these patients have chronic cystitis and are at increased risk of bladder cancer, diseases which dovetail with Dr. Hsieh’s research interests. Dr. Hsieh also is the Director of Research for the Division of Urology and the Associate Director for Science at the Sheik Zayed Institute for Pediatric Surgical Innovation. He runs an NIH-funded bladder biology research group. Dr. Hsieh has been a Recognized Doctor on the Healthgrades Honor Roll and Best Doctors in America. He has been featured several times in the New York Times for his work in robotic surgery and bladder inflammation. He attended Stanford University and returned to the East Coast for medical school at Thomas Jefferson University. During medical school, Dr. Hsieh also obtained a PhD in immunology and afterwards began exploring what would eventually become his long-term interest – the role of bladder inflammation in urinary tract infections and development of bladder cancer. He completed his urology residency training at the University of California San Francisco and pediatric urology fellowship training at Texas Children’s Hospital. As a pediatric urology fellow, Dr. Hsieh began studying how the commensal microbiome (the collection of naturally occurring, non-pathogenic bacteria in and on our bodies) may prevent urinary tract infections. Following fellowship training, he was an Assistant Professor at Stanford University, where he founded an NIH-funded research group focused on bladder inflammation, urinary tract infections and bladder cancer. Dr. Hsieh was the Administrative Director for Stanford’s Children’s Hospital Prenatal Urology and Minimally Invasive Surgery Programs. Publications Google Scholar|ORCiD. Dr. Hsieh is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Urinary Tract Infection (UTI), Undescended Testicle, Asymptomatic Bacteriuria, Trabeculectomy, and Endoscopy. Dr. Hsieh is board certified in Urology: American Board Of Urology, 2012 and Pediatric Urology: American Board Of Urology, 2012.
Frequently Asked Questions about Dr. Michael D. Keller
How do I make an appointment with Dr. Michael D. Keller?
You can book an appointment with Dr. Michael D. Keller by calling their office at 301-765-5400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Michael D. Keller a top-rated expert for Primary Ciliary Dyskinesia (PCD)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael D. Keller is classified as an Experienced expert for Primary Ciliary Dyskinesia (PCD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Michael D. Keller specialize in?
While Dr. Michael D. Keller is a Pediatrics, they have specific expertise in Primary Ciliary Dyskinesia (PCD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.
Does Dr. Michael D. Keller accept my insurance?
Dr. Michael D. Keller accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 301-765-5400 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Primary Ciliary Dyskinesia (PCD)Dr. Keller isExperienced. Learn about Primary Ciliary Dyskinesia (PCD).